文献速递疼痛医学

慢性疼痛患者药物减量的有效性:系统综述与荟萃分析

Effectiveness of pain medication tapering in chronic pain patients: a systematic review and meta-analysis.
PubMed 文献 · Br J Anaesth · 2024-10-02

该系统综述与荟萃分析旨在梳理慢性非癌痛患者减量用药影响的所有结局指标并评估减量有效性。检索至2024年4月的多个数据库,纳入57篇系统综述和34篇荟萃分析文章。随机效应三水平荟萃分析显示总体效应量为0.917(95%CI 0.61-1.22;P<0.001),提示减量有益;但纳入文章偏倚风险高,结果需谨慎解读。

要点

  • 药物减量对慢性非癌痛患者总体有益,效应量0.917(95%CI 0.61-1.22;P<0.001)。
  • 减量可显著改善疼痛强度、头痛残疾、焦虑、抑郁及阿片类药物消耗等指标。
  • 减量对躯体功能、心理健康相关生活质量等无显著效果,且证据偏倚风险高。

核心结论

  • 系统综述发现减量影响广泛的结局指标,荟萃分析显示减量总体有益,但因纳入文章高偏倚风险需谨慎解读。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE via PubMed、Web of Science、SCOPUS、EMBASE和PsycINFO从建库至2024年4月。
  • 初检识别3969篇文章,由两名独立评审员筛选,纳入评估成人慢性非癌痛患者药物减量的研究。
  • 系统综述纳入57篇文章,荟萃分析纳入34篇文章,偏倚风险评估显示质量差、中等和好的研究分别为30、24和3篇。

主要发现

  • 疼痛强度是报告最多的结局指标,共28项研究报告。
  • 随机效应三水平荟萃分析显示总体效应量为0.917(95%置信区间0.61-1.22;P<0.001),表明减量有益。
  • 减量后疼痛强度、头痛残疾、每月头痛天数、焦虑、抑郁、每月服用片剂数、每月用药天数、疼痛灾难化和疼痛干扰均有统计学显著改善。
  • 躯体功能、心理健康相关生活质量、阿片类药物使用、疼痛自我效能和身体健康相关生活质量无统计学显著效应。

关键数值与推荐

  • 总体效应量0.917(95%置信区间0.61-1.22;P<0.001)。
  • 偏倚风险评估:30篇研究质量差,24篇中等,3篇好。

临床怎么用

  • 临床可参考减量对疼痛强度、头痛残疾、焦虑抑郁及用药频率等指标的改善作用,但需结合高偏倚风险谨慎决策。

局限性

  • 纳入文章存在高偏倚风险,荟萃分析结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This systematic review and meta-analysis aimed to inventory all outcome measures that are affected by tapering in chronic noncancer pain and to investigate the effectiveness of tapering. METHODS: A literature search was conducted from inception to April 2024 in MEDLINE via PubMed, Web of Science, SCOPUS, EMBASE, and PsycINFO. RESULTS: The initial database search identified 3969 articles, which were screened by two independent reviewers. Studies evaluating pain medication tapering in adults with chronic noncancer pain were eligible for inclusion. In total, 57 and 34 articles were included in the systematic review and meta-analysis, respectively. Risk of bias assessment demonstrated poor, fair, and good quality in 30, 24, and three studies, respectively. Pain intensity was the most reported outcome measure, as reported in 28 studies. Furthermore, a random-effect three-level meta-analysis was performed. An overall effect size of 0.917 (95% confidence interval 0.61-1.22; P<0.001) was found, indicating a beneficial effect of tapering. In addition, a statistically significant improvement was demonstrated after tapering for pain intensity, headache disability, the number of headache days per month, anxiety, depression, the number of pills consumed per month, the number of days with medication intake per month, pain catastrophising, and pain interference. No statistically significant effect was observed for physical functioning, mental health-related quality of life, opioid use, pain self-efficacy, and physical health-related quality of life. CONCLUSIONS: This systematic review revealed a broad range of outcome measures affected by tapering. Owing to the high risk of bias of the included articles, the results of this meta-analysis must be interpreted with caution. SYSTEMATIC REVIEW PROTOCOL: CRD42023416343 (PROSPERO).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Wuyts E, Goudman L, Crunelle CL, et al. Effectiveness of pain medication tapering in chronic pain patients: a systematic review and meta-analysis. Br J Anaesth. 2024. PMID: 39358186. doi:10.1016/j.bja.2024.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。